Next Article in Journal
Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis
Next Article in Special Issue
Factors Influencing Decision Making Regarding the Acceptance of the COVID-19 Vaccination in Egypt: A Cross-Sectional Study in an Urban, Well-Educated Sample
Previous Article in Journal
Analyses of Safety Profile and Homologous Antibody Responses to a Mammalian Cell-Based, MF59-Adjuvanted, A/H5N1, Pandemic Influenza Vaccine across Four Phase II/III Clinical Trials in Healthy Children, Adults, and Older Adults
Previous Article in Special Issue
Factors Associated with COVID-19 Vaccine Hesitancy among Visible Minority Groups from a Global Context: A Scoping Review
 
 
Article

Article Versions Notes

Vaccines 2021, 9(12), 1469; https://doi.org/10.3390/vaccines9121469 (registering DOI)
Action Date Notes Link
article xml file uploaded 11 December 2021 10:44 CET Original file -
article xml uploaded. 11 December 2021 10:44 CET Update https://www.mdpi.com/2076-393X/9/12/1469/xml
article pdf uploaded. 11 December 2021 10:44 CET Version of Record https://www.mdpi.com/2076-393X/9/12/1469/pdf
article html file updated 11 December 2021 10:46 CET Original file -
article html file updated 30 July 2022 21:46 CEST Update https://www.mdpi.com/2076-393X/9/12/1469/html
Back to TopTop